Sangamo Therapeutics所有資訊

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)

04/05 16:04 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Duraibabu Prathyusha

02/27 17:18 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Dubois-Stringfellow Nathalie

02/27 17:18 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Willoughby Scott B.

02/27 17:17 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Pooler Amy

02/27 17:17 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Macrae Sandy

02/27 17:17 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(7.10%)

02/13 22:36 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Biogen Inc.(8.26%),Biogen MA Inc.(8.26%)

02/12 19:15 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)

02/09 12:20 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(7.9%)

01/26 11:54 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Pooler Amy

01/24 16:46 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Willoughby Scott B.

01/24 16:45 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Duraibabu Prathyusha

01/24 16:45 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Dubois-Stringfellow Nathalie

01/24 16:45 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Macrae Sandy

01/24 16:41 (美東)

Sangamo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-STATE STREET CORPORATION(1.53%)

01/22 00:00 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Willoughby Scott B.

2023/11/28 16:20 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 McClung David Mark

2023/11/28 16:19 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Macrae Sandy

2023/11/28 16:19 (美東)

Sangamo Therapeutics | 4：持股變動聲明-高管 Fontenot Jason D.

2023/11/28 16:18 (美東)